Hunter Cancer Biobank

The Hunter Cancer Biobank (HCB) was first established in 2012 as a joint initiative of Hunter Cancer Research Alliance (HCRA), Pathology North (Hunter New England) and Hunter New England Local Health District (HNE LHD). HCB values the delivery of high quality services and operates in accordance with all national and international guidelines. Feel free to contact us for further information on how we can help you deliver the cancer research outcomes you expect with high quality pathological specimens.

HCB process cycle from sample collection to distribution

The University of Newcastle, Australia Hunter New England Local Health District Calvary Mater Newcastle Hunter Medical Research Institute Cancer Institute NSW Pathology North